Myomo Inc.

Burlington, MA

UEI
RHUZFJ4KJ3J1
CAGE
481B3
Primary NAICS
339112 Surgical and Medical Instrument Manufacturing
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
45 Network Dr Suite 101, Burlington, MA 01803, USA
Website
myomo.com
Founded
2004
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $697,770
FY2025 $759,180
FY2024 $1,339,085
FY2023 $1,130,125

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $697,770

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
University Of Pittsburgh - Of The Commonwealth System Of Higher Education PFI-RP: Use of Augmented Reality and Electroencephalography for Visual Unilateral Neglect Detection, Assessment and Rehabilitation in Stroke Patients 2234346 $48,000

Similar vendors

About the company

Myomo Inc., a Burlington, Massachusetts-based for-profit medical device manufacturer, sells powered myoelectric orthotic and prosthetic devices to the Department of Veterans Affairs as a prime contractor through purchase orders across nearly all Veterans Integrated Service Networks (VISNs). The company operates exclusively on full-and-open federal procurements with no set-aside designations, selling individual MyoPro and MyoPro 2+ upper limb systems and custom components valued between $15,600 and $120,000 per award.

Myomo's federal footprint is heavily concentrated within the VA system. The five leading customer VISNs account for 52% of the vendor's 337 total awards and 51% of combined potential value. VA VISN 10 anchors the portfolio with 49 awards worth $1.4 million combined potential value, followed by VISN 8 (42 awards, $1 million), VISN 22 (35 awards, $798 thousand), VISN 20 (28 awards, $667 thousand), and VISN 7 (21 awards, $535 thousand). All work flows through the Department of Veterans Affairs Veterans Health Administration, with no other federal agencies represented in the active award set. The portfolio spans 22 distinct customer agencies in the source data, though the VA dominates overwhelmingly; the vendor has delivered more than 200 individual purchase orders to the VA system since 2021 according to internal award summaries.

Myomo's capability portfolio centers on myoelectric orthotic and prosthetic systems for upper limb paralysis and weakness restoration. The MyoPro and MyoPro 2+ product lines utilize motion-sensing technology and functional electrical stimulation (neuromuscular stimulation) to enable arm and hand function for individuals with upper limb disabilities. Typical deliverables include custom-fabricated devices, integrated software, shoulder harnesses, and clinical staff training. Representative awards span the past four years: a $31,635 purchase order from VISN 10 in August 2026 for a MyoPro 2X with Motion Grasp right orthosis; a $31,635 award from VISN 17 in August 2026 for an orthotic device; a $31,635 purchase order from VISN 22 in August 2026 for prosthetics and artificial limb/orthotics; and a $120,000 sole-source contract from VISN 10 awarded in August 2022 for nine MyoPro 2+ devices with motion grasp capabilities available over one year, procured under simplified acquisition procedures as the government determined Myomo was the only source capable of meeting clinical requirements.

Activity has moderated in recent years. The vendor received 46 awards in 2022, declined to 43 in 2023 and 42 in 2024, then dropped to 25 in 2025 and 23 in 2026. Nine awards (combined potential value $285 thousand) reach completion within the next twenty-four months, creating modest recompete exposure. The vendor's NAICS profile is dominated by surgical appliance and supplies manufacturing (280 awards), with secondary exposure in surgical and medical instrument manufacturing (48 awards), reflecting the device-fabrication and customization nature of the work.

Myomo appears in the source as a sub-recipient on one National Science Foundation-funded research partnership grant led by the University of Pittsburgh, focused on augmented reality and electroencephalography applications for visual unilateral neglect detection, assessment, and rehabilitation in stroke patients. Otherwise, the vendor's federal activity is almost entirely VA device supply via firm fixed-price purchase orders across service networks nationwide, with no major subcontractor involvement reported.

Quick answers

Is Myomo Inc. registered in SAM.gov?

Yes. Myomo Inc.'s SAM.gov registration is active through March 20, 2027.

How much has Myomo Inc. received in federal contracts?

Federal contracts obligated $759,180 to Myomo Inc. in fiscal year 2025 and $3,926,160 in fiscal years 2023 through 2027.

How does Myomo Inc. rank among federal contractors?

Myomo Inc. ranked #46 in PSC 6510 in FY2025.

What is Myomo Inc.'s most recent federal award?

Myomo Inc.'s most recent federal contract award is Power orthosis (36C25026P1000), from Veterans Integrated Service Network 10 (VHA), on August 24, 2026.

On GovTribe

See Myomo Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors